52 results
Page 2 of 3
6-K
EX-1.1
jggbnfuquwh
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
8u9fx
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
4nccaye cz4lkp4e0x
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
kg8sk1x f0f5
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
438 2olhsjoyu5r
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
f1z35zxvj2j51d2
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
vx6 fzppv2id4v38czh0
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
hsm2623mq0
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
c374h
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
uuoe6pwruw83tm
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
67hrh1gsn2oqqhucs7xc
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
phg 6yjkleuubgd
10 Jul 19
Prospectus supplement
8:18am
F-3
5p5nhd8qd
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
8fcdhvq1jh9 29wla
7 Jun 19
Shelf registration (foreign)
3:31pm